Showing results (1-10 of 4,673) with videos related to
Sort By:
Pageof 468
Surgical Oncology Clinics of North America|May 14, 2019
Immunologic Targeting of Cancer Stem CellsJing Zhang, Qiao Li, Alfred E ChangCancer Research|December 18, 2019
Integrin β4-Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease MetastasisShasha Ruan, Ming Lin, Yong Zhu, et al.Frontiers in Immunology|August 15, 2022
Emerging concepts regarding pro- and anti tumor properties of B cells in tumor immunityYou Qin, Furong Lu, Kexing Lyu, et al.International Journal of Biological Sciences|December 12, 2007
Adjuvant effect of anti-4-1BB mAb administration in adoptive T cell therapy of cancerQiao Li, Takekazu Iuchi, Maria N Jure-Kunkel, et al.Clinical Immunology (Orlando, Fla.)|October 11, 2008
Dendritic cells pulsed with keyhole limpet hemocyanin and cryopreserved maintain anti-tumor activity in a murine melanoma modelSeagal Teitz-Tennenbaum, Qiao Li, Mary A Davis, et al.Oncoimmunology|December 18, 2012
Targeting cancer stem cells via dendritic-cell vaccinationSeagal Teitz-Tennenbaum, Max S Wicha, Alfred E Chang, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2002
Therapeutic effects of tumor reactive CD4+ cells generated from tumor-primed lymph nodes using anti-CD3/anti-CD28 monoclonal antibodiesQiao Li, Bo Yu, Amelia C Grover, et al.Cancer Research|May 17, 2003
Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapyQiao Li, Abbey Carr, Fumito Ito, et al.Oncotarget|September 10, 2021
Targeting cancer stem cells via integrin β4Hannah E Dobson, Shasha Ruan, Alfred E Chang, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 14, 2003
Antitumor reactivity of anti-CD3/anti-CD28 bead-activated lymphoid cells: implications for cell therapy in a murine modelFumito Ito, Abbey Carr, Hakan Svensson, et al.Pageof 468